androstenedione has been researched along with pituitrin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gaillard, RC; Ling, N; Muller, AF; Riondel, AM | 1 |
| Martini, L | 1 |
1 review(s) available for androstenedione and pituitrin
| Article | Year |
|---|---|
The 5alpha-reduction of testosterone in the neuroendocrine structures. Biochemical and physiological implications.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; Androgens; Androstane-3,17-diol; Androstenedione; Animals; Birds; Castration; Dihydrotestosterone; Estrogens; Female; Gonadotropin-Releasing Hormone; Gonadotropins, Pituitary; Humans; Hypothalamus; Light; Male; Oxidoreductases; Periodicity; Pineal Gland; Pituitary Gland, Anterior; Prolactin; Receptors, Androgen; Sexual Behavior; Sexual Maturation; Testosterone; Vasopressins | 1982 |
1 trial(s) available for androstenedione and pituitrin
| Article | Year |
|---|---|
Corticotropin releasing factor activity of CRF 41 in normal man is potentiated by angiotensin II and vasopressin but not by desmopressin.
Topics: Adrenocorticotropic Hormone; Adult; Androstenedione; Angiotensin II; Corticotropin-Releasing Hormone; Deamino Arginine Vasopressin; Dehydroepiandrosterone; Drug Synergism; Humans; Hydrocortisone; Kinetics; Male; Vasopressins | 1988 |